HCIT, I believe the analysis of the rest that t
Post# of 148175
I believe the analysis of the rest that there is a lot of uncertainty due to past investor updates that did not play out as expected.
My larger belief is that most investors and the larger markets just don’t know what to make of this company or leronlimab.
Most of us appreciate the change in medicine that leronlimab will have. Many thanks to Dr. Patterson and then ohm20 here.
The ostensibly professional analysts are often unable to cogently discuss vaccines, preventative mAbs (Regeneron), therapeutic mAbs (Leronlimab, lenzilumab) , immune stimulators (Synairgen’s interferon) and the various types of vaccines.
I am not surprised that the stock is trading completely sideways.
I feel as though we have been spoon fed the answer to Covid with Patterson’s manuscript and follow up videos.
Millions are about to be shocked, even though we collectively have been screaming about leronlimab for months.
I’ll be very happy to shake my head in disbelief as the larger community asks why they didn’t know about this sooner.
We tried to tell them, but they refused to listen. I believe we will be in a new world by Monday.